Harmless Herbs? Think Again: Merits of a Complete Medication History

Journal of the American Medical Directors Association

Volumn 7, Issue 7, 2006, Pages 446-447

  Beier, Manju T ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOCHROME P450 2C19; GINKGO BILOBA EXTRACT; HUPERZINE A; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BLEEDING; BRADYCARDIA; CHINESE MEDICINE; CLINICAL TRIAL; DEMENTIA; DIARRHEA; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DRUG SAFETY; DRUG UTILIZATION; FOOD AND DRUG ADMINISTRATION; FREQUENCY ANALYSIS; GOOD MANUFACTURING PRACTICE; HERBAL MEDICINE; HUMAN; INTERNET; NAUSEA; RETINA HEMORRHAGE; SEIZURE; STANDARDIZATION; SUBDURAL HEMATOMA; VOMITING;

EID: 33748529301     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2006.05.013     Document Type: Article

References (10)

1. The National Center for Complementary and Alternative Medicine (NCCAM). Available at: http://nccam.nih.gov/health/supplement-safety/. Accessed May 2, 2006
2. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 136 1 (2002) 42-53
3. Clinical Trials.gov. Ginkgo biloba prevention trial in older individuals (2006). http://www.clinicaltrials.gov/ct/show/NCT00010803?order=1 Available at: http://www.clinicaltrials.gov/ct/show/NCT00010803?order=1. Accessed May 3
4. Sierpina V.S., Wollschlaeger B., and Blumenthal M. Ginkgo biloba. Am Fam Physician 68 (2003) 923-926
5. Kupiec T., and Raj V. Fatal seizures due to potential herb-drug interactions with Ginkgo biloba. J Anal Toxicol 29 7 (2005) 755-758
6. Gregory P.J. Seizure associated with Ginkgo biloba?. Ann Intern Med 134 (2001) 344
7. Granger A.S. Ginkgo biloba precipitating epileptic seizures. Age Aging 30 (2001) 523-525
8. Natural Medicines Comprehensive Database. Stockton, CA: Therapeutic Research Faculty. Available at: www.naturaldatabase.com/. Accessed May 3, 2006.
9. Wang R., and Tang X.C. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease. Neurosignals 14 1-2 (2005) 71-82
10. Huperzine A in Alzheimer's disease (2006). http://Clinical%20Trials.gov Clinical Trials.gov. Available at: http://www.clinicaltrials.gov/ct/show/NCT00083590?order=8. Accessed May 3